PAD: Shockwave Medical raises $40M

May 19, 2015 by Fink Densford

Shockwave Medical announced $40 million in funding for its novel balloon catheter designed to treat calcified lesions in the peripheral vasculature.

Investors include prior backer Sofinnova Partners and newcomer Venrock, as well as RA Capital, Deerfield, Sectoral Asset Management, Ally Bridge group and 2 undisclosed large-cap investors, Fremont, Calif.-based Shockwave said. Read more

PAD: Intact Vascular raises $39m for Tack device

May 15, 2015 by Brad Perriello

Intact Vascular said it brought in a $38.9 million Series B round it plans to use to get its Tack endovascular device through the FDA approval process.

Wayne, Pa.-based Intact said the round was led by New Enterprise Assoc. and included Quaker Partners, H.I.G. BioVentures and other prior backers. NEA director Dr. Justin Klein is slated to join the company’s board as part of the round, Intact said. Read more

ConvaTec plans $1.9B refi

May 18, 2015 by Mark Hollmer

ConvaTec, which just named a new CEO and is rumored to be up for sale, plans to raise nearly $1.9 billion in loan and credit facilities in a debt-refinancing move.

The Luxembourg-based medical device company will seek $1.65 billion in term loan facilities and a $200 million revolving credit facility, both due in 2020. Plans call for using the money to refinance existing credit facilities and senior secured notes, the company said. Read more

Outset Medical raises $60m for home dialysis device

May 20, 2015 by Fink Densford

Outset Medical, previously Home Dialysis Plus, said it raised $60 million from 9 unnamed investors as it prepares to go head to head with NxStage Medical on the home hemodialysis front.

Outset touts its new device, the Tablo, as the 1st dialysis machine designed as a consumer product, according to Warburg Pincus. The Vertical Group is also an investor, according to Outset’s website. Read more

Smith & Nephew gets in on OrthoSpace round

May 21, 2015 by Fink Densford

OthoSpace said this week that it completed “significant” but unspecified financing for its InSpace biodegradable orthopedic balloon, led by Healthpoint Capital with participation from Smith & Nephew and Triventures.

The InSpace device is a minimally invasive orthopedic balloon designed for use in rotator cuff repairs. Read more

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW